As of 2024-12-15, the Fair Value of Tarsus Pharmaceuticals, Inc. (TARS) is -17.57 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 52.50 USD, the upside of Tarsus Pharmaceuticals, Inc. is -133.47%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -4.67 | -26.81 | -13.83 | -62.09 | -135.89 | -48.66 |
| YoY growth | -253.79% | -474.09% | 48.41% | -348.95% | -118.86% | -229.46% |
| Market Cap (mil) | 2,007.08 |
| P/E | |
| Forward P/E |
| EPS | -3.51 |
| Avg earnings growth rate | -229.46% |
| TTM earnings | -134.34 |